A study based on the NHP model demonstrated that vaccine-induced strong neutralizing antibody and CD8+ T-cell responses can protect the lungs from SARS-CoV-2 infection and viral replication early in infection (days 2-4) (271). The gene discussed is CD8A; the disease is infection.